These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34423713)

  • 1. UDP-glucuronosyltransferase 1A4-mediated N2-glucuronidation is the major metabolic pathway of lamotrigine in chimeric NOG-TKm30 mice with humanised-livers.
    Uehara S; Higuchi Y; Yoneda N; Yamazaki H; Suemizu H
    Xenobiotica; 2021 Oct; 51(10):1146-1154. PubMed ID: 34423713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Unique Human N10-Glucuronidated Metabolite Formation from Olanzapine in Chimeric NOG-TKm30 Mice with Humanized Livers.
    Uehara S; Higuchi Y; Yoneda N; Kato H; Yamazaki H; Suemizu H
    Drug Metab Dispos; 2023 Apr; 51(4):480-491. PubMed ID: 36623885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UGT2B10 is the Major UDP-Glucuronosyltransferase 2B Isoform Involved in the Metabolism of Lamotrigine and is Implicated in the Drug-Drug Interaction with Valproic Acid.
    Tang LWT; Lapham K; Goosen TC
    AAPS J; 2024 Sep; 26(6):107. PubMed ID: 39322784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction.
    Rowland A; Elliot DJ; Williams JA; Mackenzie PI; Dickinson RG; Miners JO
    Drug Metab Dispos; 2006 Jun; 34(6):1055-62. PubMed ID: 16565174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl-hydroxylation and subsequent oxidation to produce carboxylic acid is the major metabolic pathway of tolbutamide in chimeric TK-NOG mice transplanted with human hepatocytes.
    Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
    Xenobiotica; 2021 May; 51(5):582-589. PubMed ID: 33455497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7.
    Seo KA; Bae SK; Choi YK; Choi CS; Liu KH; Shin JG
    Drug Metab Dispos; 2010 Nov; 38(11):2007-13. PubMed ID: 20713656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4.
    Kaku T; Ogura K; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
    Biochem Pharmacol; 2004 Jun; 67(11):2093-102. PubMed ID: 15135306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative metabolism and pharmacokinetics of the EGFR inhibitor BIBX1382 in chimeric NOG-TKm30 mice transplanted with human hepatocytes.
    Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
    Drug Metab Pharmacokinet; 2021 Dec; 41():100419. PubMed ID: 34624627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quaternary ammonium-linked glucuronidation of trans-4-hydroxytamoxifen, an active metabolite of tamoxifen, by human liver microsomes and UDP-glucuronosyltransferase 1A4.
    Ogura K; Ishikawa Y; Kaku T; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
    Biochem Pharmacol; 2006 Apr; 71(9):1358-69. PubMed ID: 16480962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of afloqualone N-glucuronidation: species differences and identification of human UDP-glucuronosyltransferase isoform(s).
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Jan; 33(1):60-7. PubMed ID: 15475412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig.
    Higashi E; Ando A; Iwano S; Murayama N; Yamazaki H; Miyamoto Y
    Biopharm Drug Dispos; 2014 Sep; 35(6):313-20. PubMed ID: 24752421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation.
    Vaillancourt J; Turcotte V; Caron P; Villeneuve L; Lacombe L; Pouliot F; Lévesque É; Guillemette C
    Drug Metab Dispos; 2020 Feb; 48(2):75-84. PubMed ID: 31727674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
    Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
    Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro hepatic metabolism of cediranib, a potent vascular endothelial growth factor tyrosine kinase inhibitor: interspecies comparison and human enzymology.
    Schulz-Utermoehl T; Spear M; Pollard CR; Pattison C; Rollison H; Sarda S; Ward M; Bushby N; Jordan A; Harrison M
    Drug Metab Dispos; 2010 Oct; 38(10):1688-97. PubMed ID: 20634336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes.
    Magdalou J; Herber R; Bidault R; Siest G
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1166-73. PubMed ID: 1545383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of the glucuronidation pathways of licochalcone A mediated by human UDP-glucuronosyltransferases.
    Xia YL; Dou TY; Lv X; Ge GB
    Xenobiotica; 2019 Jun; 49(6):671-677. PubMed ID: 30044687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of 2-[[4-[[2-(1H-tetrazol-5-ylmethyl)phenyl]methoxy]methyl]quinoline N-glucuronidation by in vitro and in vivo approaches.
    Stevens JC; Fayer JL; Cassidy KC
    Drug Metab Dispos; 2001 Mar; 29(3):289-95. PubMed ID: 11181497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly selective N-glucuronidation of four piperazine-containing drugs by UDP-glucuronosyltransferase 2B10.
    Lu D; Dong D; Wu B
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):989-998. PubMed ID: 30049229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucuronidation of a sarpogrelate active metabolite is mediated by UDP-glucuronosyltransferases 1A4, 1A9, and 2B4.
    Kim HJ; Jeong ES; Seo KA; Shin KJ; Choi YJ; Lee SJ; Ghim JL; Sohn DR; Shin JG; Kim DH
    Drug Metab Dispos; 2013 Aug; 41(8):1529-37. PubMed ID: 23704698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.